Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Solu Therapeutics in the transaction. Solu Therapeutics announced the closing of an oversubscribed $31 million seed financing co-led...
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Solu Therapeutics in the transaction. Solu Therapeutics announced the closing of an oversubscribed $31 million seed financing co-led...
You must be a Standard 1 Year member to access this content.